U.S., June 23 -- ClinicalTrials.gov registry received information related to the study (NCT07659639) titled 'Biophotonic Nanoparticle-enabled Laser Blood Test for Early Detection of Pancreatic Cancer' on May 21, 2025.
Brief Summary: LASERBLOOD is based on a biophotonic technology that can be used to predict the development of Pancreatic Ductal Adenocarcinoma (PDAC) in particular categories of subjects at risk (e.g. persons with diabetes, obese people, patients with Intraductal Papillary Mucinous Neoplasm [IPMN] or other cystic diseases of the pancreas, etc.) and at the same time offer the possibility of verifying the real effectiveness of the treatments to which affected patients are subjected.
Study Start Date: Sept. 01, 2025
Study Type...